Navidea Biopharmaceuticals, Inc. (NAVB)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Aug 1, 2025, 2:53 PM EDT
Accolade Market Cap
NAVB has a market cap or net worth of $50.00 thousand as of August 1, 2025. Its market cap has decreased by -98.75% in one year.
Market Cap
50.00K
Enterprise Value
n/a
Revenue
610.00
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 10, 1992, NAVB's market cap has decreased from 4.93M to 50.00K, a decrease of -98.99%. That is a compound annual growth rate of -13.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 50.00K | 400.02% |
| Dec 31, 2024 | 10.00K | -99.82% |
| Dec 29, 2023 | 5.52M | -18.56% |
| Dec 30, 2022 | 6.78M | -77.52% |
| Dec 31, 2021 | 30.15M | -47.33% |
| Dec 31, 2020 | 57.25M | 151.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 366.82M |